Subscribe To

Price Alert Latest News Economic Calendar News

ZYXI / Zynex's (ZYXI) CEO Thomas Sandgaard on Q1 2022 Results - Earnings Call Transcript

Zynex, Inc. (NASDAQ:ZYXI ) Q1 2022 Earnings Conference Call April 28, 2022 4:15 PM ET Company Participants Louisa Smith – Investor Relations-Gilmartin Group Thomas Sandgaard – Chairman, President and Chief Executive Officer Anna Lucsok – Chief Operating Officer Don Gregg – Vice President of Zynex Monitoring Solutions Dan Moorhead – Chief Financial Officer Conference Call Participants Marc Wiesenberger – BRiley Jeffrey Cohen – Ladenburg Thalmann Yi Chen – H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Read More

Demo Live Account See Partner Details

Content Topics

Zynex

ZYXI

Thomas

Sandgaard

2022

Results

Earnings

Call

Zynex s

zyxi

Transcript

Stock

Posted: Apr 28 2022, 21:10

Author Name: Seeking Alpha

ZYXI News

By Zacks Investment Research
October 26, 2023

Zynex Inc. (ZYXI) Q3 Earnings Match Estimates

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.13 p

By Seeking Alpha
October 3, 2023

Zynex: A Reassessment

Zynex, Inc. is a pain management company that manufactures and markets medical devices for chronic and acute pain treatment. The stock has fallen by h

By PRNewsWire
September 19, 2023

Zynex to Present at the Cantor Global Healthcare Conference

ENGLEWOOD, Colo. , Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture

By Seeking Alpha
July 27, 2023

Zynex, Inc. (ZYXI) Q2 2023 Earnings Call Transcript

Zynex, Inc. (NASDAQ:ZYXI ) Q2 2023 Earnings Conference Call July 27, 2023 4:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas S

By Zacks Investment Research
July 27, 2023

Zynex Inc. (ZYXI) Q2 Earnings and Revenues Surpass Estimates

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earni

By PRNewsWire
July 20, 2023

Zynex, Inc. Sets Second Quarter 2023 Earnings Call

ENGLEWOOD, Colo. , July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture

By Seeking Alpha
July 16, 2023

Zynex: Strong Growth And Profitability Amid Financial Concerns

Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in

By The Motley Fool
June 14, 2023

Why Shares of Zynex Are Up Wednesday

Zynek makes electrotherapy devices to control pain. The company grew revenue and net income in the first quarter.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.